Caricamento...
Phase II Study of Daily Sunitinib in FDG-PET Positive, Iodine Refractory, Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of Thyroid with Functional Imaging Correlation
PURPOSE: We conducted a phase II study to assess the efficacy of continuous dosing of sunitinib in patients with FDG-PET avid, iodine refractory, well-differentiated thyroid carcinoma (WDTC) and medullary thyroid cancer (MTC), and to assess for early response per FDG-PET. EXPERIMENTAL DESIGN: Patien...
Salvato in:
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3063514/ https://ncbi.nlm.nih.gov/pubmed/20847059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-0994 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|